Tag: Orange Book patents

Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines

Patent litigation in generic drug markets is delaying affordable medicines, costing billions annually. Learn how the Hatch-Waxman Act, Orange Book listings, and pay-for-delay settlements are shaping access to generics.

learn more